2026.03.31

Points to Consider for Clinical Development of PSMA-PET Radiopharmaceuticals in Japan
Introduction to Regulatory Considerations According to the document issued by the Pharmaceuticals and Medical […]
2026.03.31

Introduction to Regulatory Considerations According to the document issued by the Pharmaceuticals and Medical […]